Quince Therapeutics, Inc. - Common Stock (NQ: QNCX )
0.6963
-0.0037
(-0.53%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 5, 2024
Add to My Watchlist
Press Releases about Quince Therapeutics, Inc. - Common Stock
![](https://mms.businesswire.com/media/20240903061244/en/1528430/22/Quince_Therapeutics_Logo.jpg)
![](https://mms.businesswire.com/media/20240815940181/en/1528430/22/Quince_Therapeutics_Logo.jpg)
![](https://mms.businesswire.com/media/20240813990780/en/1528430/22/Quince_Therapeutics_Logo.jpg)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://mms.businesswire.com/media/20240625494765/en/1528430/22/Quince_Therapeutics_Logo.jpg)
![](https://mms.businesswire.com/media/20240603425785/en/1528430/22/Quince_Therapeutics_Logo.jpg)
![](https://mms.businesswire.com/media/20240513538230/en/1528430/22/Quince_Therapeutics_Logo.jpg)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Via ACCESSWIRE
![](https://mms.businesswire.com/media/20240506671205/en/1528430/22/Quince_Therapeutics_Logo.jpg)
![](https://mms.businesswire.com/media/20240329372032/en/1528430/22/Quince_Therapeutics_Logo.jpg)
![](https://mms.businesswire.com/media/20240222393006/en/1528430/22/Quince_Therapeutics_Logo.jpg)
Quince Therapeutics Launches Scientific Advisory Board
February 22, 2024
Via Business Wire
![](https://mms.businesswire.com/media/20240215193487/en/1528430/22/Quince_Therapeutics_Logo.jpg)
![](https://mms.businesswire.com/media/20240207118051/en/1528430/22/Quince_Therapeutics_Logo.jpg)
![](https://mms.businesswire.com/media/20240104212468/en/1528430/22/Quince_Therapeutics_Logo.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20231023815692/en/1528430/22/Quince_Therapeutics_Logo.jpg)
Quince Therapeutics Completes Acquisition of EryDel S.p.A.
October 23, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230928420547/en/1528430/22/Quince_Therapeutics_Logo.jpg)
![](https://mms.businesswire.com/media/20230906220898/en/1528430/22/Quince_Therapeutics_Logo.jpg)
Quince Therapeutics Appoints Dr. Charles S. Ryan as President
September 06, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230810799693/en/1528430/22/Quince_Therapeutics_Logo.jpg)
![](https://mms.businesswire.com/media/20230724507851/en/1528430/22/Quince_Therapeutics_Logo.jpg)
![](https://mms.businesswire.com/media/20230411005370/en/1528430/22/Quince_Therapeutics_Logo.jpg)
![](https://mms.businesswire.com/media/20230406005665/en/1528430/22/Quince_Therapeutics_Logo.jpg)
![](https://mms.businesswire.com/media/20230405005633/en/1528430/22/Quince_Therapeutics_Logo.jpg)
![](https://mms.businesswire.com/media/20230322005286/en/1528430/22/Quince_Therapeutics_Logo.jpg)
![](https://mms.businesswire.com/media/20230130005565/en/1528430/22/Quince_Therapeutics_Logo.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20230127005086/en/1528430/22/Quince_Therapeutics_Logo.jpg)
![](https://mms.businesswire.com/media/20220916005037/en/1528430/5/Quince_Therapeutics_Logo.jpg)
![](https://mms.businesswire.com/media/20220912005365/en/1528430/5/Quince_Therapeutics_Logo.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.